Pharmacokinetic Profile of Rosemary Extract Supplement

CJ CheilJedang12 enrolled

Overview

This study is a clinical trial to observe changes in biomarkers in the blood at pre- and post-supplementation of rosemary extract in healthy adults.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

OTHER

Masking

TRIPLE

Enrollment

Conditions

Pharmacokinetics

Interventions

Rosemary extractDIETARY_SUPPLEMENT

Softgel capsule including rosemary extract

Eligibility

Sex: ALLMin age: 25 YearsMax age: 55 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Healthy subjects aged between 25 and 55 years * Non-smoker * Body Mass Index (BMI) between 20 and 30 kg/m2 Exclusion Criteria: * Any history or presence of cardiovascular, pulmonary, gastro-intestinal, hepatic, renal, endocrine, metabolic, hematological, neurologic, psychiatric, systemic or infectious disease

Outcomes

Primary Outcomes

Concentration in plasma

Time frame: 24 hours

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.